method development analysis anti diabetic di patel kandarp (9 risultati)

Condizione: New. pp. 64.

Condizione: New.

Taschenbuch. Condizione: Neu. Method Development For Analysis Of Anti-Diabetic Combination | Kandarp M. Patel (u. a.) | Taschenbuch | 64 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659384707 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Day to day numbers of newer drugs and their formulations either in single or in combined dosage forms are marketed. Epalrestat and Metformin HCl is one of the new combination available for the treatment of Diabetes. This combination is not official in any pharmacopoeia; hence no official method or reported methods are available for the estimation of these two drugs in combined dosage forms. So it is rational to develop and validate the Analytical methods for the estimation of these drugs. With the light of above objective, Reverse phase HPLC, Simultaneous estimation by UV spectrophotometer and HPTLC methods were developed and validated for analysis of combination of Epalrestat and Metformin HCl. 64 pp. Englisch.

Condizione: New. Print on Demand pp. 64 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Patel Kandarp M.MR. KANDARP MADHUBHAI PATEL (Master of Pharmacy in Quality Assurance, PGDRA, FICS)Day to day numbers of newer drugs and their formulations either in single or in combined dosage forms are.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Day to day numbers of newer drugs and their formulations either in single or in combined dosage forms are marketed. Epalrestat and Metformin HCl is one of the new combination available for the treatment of Diabetes. This combination is not official in any pharmacopoeia; hence no official method or reported methods are available for the estimation of these two drugs in combined dosage forms. So it is rational to develop and validate the Analytical methods for the estimation of these drugs. With the light of above objective, Reverse phase HPLC, Simultaneous estimation by UV spectrophotometer and HPTLC methods were developed and validated for analysis of combination of Epalrestat and Metformin HCl.

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Day to day numbers of newer drugs and their formulations either in single or in combined dosage forms are marketed. Epalrestat and Metformin HCl is one of the new combination available for the treatment of Diabetes. This combination is not official in any pharmacopoeia; hence no official method or reported methods are available for the estimation of these two drugs in combined dosage forms. So it is rational to develop and validate the Analytical methods for the estimation of these drugs. With the light of above objective, Reverse phase HPLC, Simultaneous estimation by UV spectrophotometer and HPTLC methods were developed and validated for analysis of combination of Epalrestat and Metformin HCl.Books on Demand GmbH, Überseering 33, 22297 Hamburg 64 pp. Englisch.